Page 119 - Read Online
P. 119

Page 16 of 17                                                    Arisha et al. Vessel Plus 2018;2:14  I  http://dx.doi.org/10.20517/2574-1209.2018.29

                   patients undergoing percutaneous coronary interventions. Cardiovasc Revascularization Med Mol Interv 2016;17:233-40.
               80.  McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, Peterson ED, Blaney M, Frederick PD, Krumholz HM; NRMI
                   Investigators. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll
                   Cardiol 2006;47:2180-6.
               81.  Yudi MB, Ramchand J, Farouque O, Andrianopoulos N, Chan W, Duffy SJ, Lefkovits J, Brennan A, Spencer R, Fernando D, Hiew C,
                   Freeman M, Reid CM, Ajani AE, Clark DJ; Melbourne Interventional Group. Impact of door-to-balloon time on long-term mortality in
                   high- and low-risk patients with ST-elevation myocardial infarction. Int J Cardiol 2016;224:72-8.
               82.  Swaminathan RV, Wang TY, Kaltenbach LA, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN. Nonsystem reasons for
                   delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry. J Am Coll
                   Cardiol 2013;61:1688-95.
               83.  Angeja BG, Gibson CM, Chin R, Frederick PD, Every NR, Ross AM, Stone GW, Barron HV; Participants in the National Registry of
                   Myocardial Infarction 2-3. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol 2002;89:1156-61.
               84.  Engberding N, Wenger NK. Acute coronary syndromes in the elderly. F1000Research 2017;6:1791.
               85.  Kim HY, Choi JH. How to utilize coronary computed tomography angiography in the treatment of coronary artery disease. J Cardiovasc
                   Ultrasound 2015;23:204-8.
               86.  Karacsonyi J, Alaswad K, Jaffer FA, Yeh RW, Patel M, Bahadorani J, Karatasakis A, Danek BA, Doing A, Grantham JA, Karmpaliotis D,
                   Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Alame A, Nguyen-Trong PKJ,
                   Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES. Use of intravascular imaging during chronic total
                   occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Am Heart Assoc 2016;5:e003890.
               87.  Danzi GB, Campanile A, Sozzi FB, Bonanomi C. Retrograde dissection during percutaneous coronary intervention: sealing of the entry
                   site by covered stent implantation. BMJ Case Rep 2012;2012:bcr0320126014.
               88.  Chen HC, Lee WC, Fu M. “Rail track picture”: diagnosis of the protruding of left main coronary stent by transthoracic echocardiography
                   especially with three-dimensional images. Eur Heart J Cardiovasc Imaging 2014;15:946.
               89.  Arisha MJ, Hsiung MC, Ahmad A, Nanda NC, Elkaryoni A, Mohamed AH, Yin WH. Incremental benefit of three-dimensional
                   transesophageal echocardiography in the assessment of left main coronary artery stent protrusion. Echocardiogr Mt Kisco N
                   2017;34:915-8.
               90.  De Maria GL, Banning AP. Use of intravascular ultrasound imaging in percutaneous coronary intervention to treat left main coronary
                   artery disease. Interv Cardiol Lond Engl 2017;12:8-12.
               91.  Terashima M, Kaneda H, Suzuki T. The role of optical coherence tomography in coronary intervention. Korean J Intern Med
                   2012;27:1-12.
               92.  Larose E, Côté J, Rodés-Cabau J, Noël B, Barbeau G, Bordeleau E, Miró S, Brochu B, Delarochellière R, Bertrand OF. Contrast-
                   enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction. Int J Cardiovasc Imaging
                   2009;25:519-27.
               93.  Oqueli E, Dick R. Percutaneous coronary intervention in very elderly patients. In-hospital mortality and clinical outcome. Heart Lung
                   Circ 2011;20:622-8.
               94.  Parikh R, Chennareddy S, Debari V, Hamdan A, Konlian D, Shamoon F, Bikkina M. Percutaneous coronary interventions in
                   nonagenarians: in-hospital mortality and outcome at one year follow-up. Clin Cardiol 2009;32:E16-21.
               95.  Teplitsky I, Assali A, Lev E, Brosh D, Vaknin-Assa H, Kornowski R. Results of percutaneous coronary interventions in patients > or
                   =90 years of age. Catheter Cardiovasc Interv 2007;70:937-43.
               96.  Spoon DB, Psaltis PJ, Singh M, Holmes DR, Gersh BJ, Rihal CS, Lennon RJ, Moussa ID, Simari RD, Gulati R. Trends in cause of
                   death after percutaneous coronary intervention. Circulation 2014;129:1286-94.
               97.  Peiyuan H, Jingang Y, Haiyan X, Xiaojin G, Ying X, Yuan W, Wei L, Yang W, Xinran T, Ruohua Y, Chen J, Lei S, Xuan Z, Rui F,
                   Yunqing Y, Qiuting D, Hui S, Xinxin Y, Runlin G, Yuejin Y; CAMI Registry study group. The comparison of the outcomes between
                   primary PCI, fibrinolysis, and no reperfusion in patients ≥ 75 years old with ST-segment elevation myocardial infarction: results from
                   the Chinese Acute Myocardial Infarction (CAMI) Registry. PLoS One 2016;11:e0165672.
               98.  Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy
                   Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
                   N Engl J Med 1997;336:1621-8.
               99.  de Boer SPM, Westerhout CM, Simes RJ, Granger CB, Zijlstra F, Boersma E; Primary Coronary Angioplasty Versus Thrombolysis-2
                   (PCAT-2) Trialists Collaborators Group. Mortality and morbidity reduction by primary percutaneous coronary intervention is
                   independent of the patient’s age. JACC Cardiovasc Interv 2010;3:324-31.
               100. Solhpour A, Chang KW, Balan P, Cai C, Sdringola S, Denktas AE, Smalling RW, Anderson HV. Comparison of outcomes for patients
                   ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous
                   coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol 2014;113:60-3.
               101. Nicolini F, Contini GA, Fortuna D, Pacini D, Gabbieri D, Vignali L, Campo G, Manari A, Zussa C, Guastaroba P, De Palma R,
                   Gherli T. Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results. Ann Thorac Surg
                   2015;99:567-74.
               102. Sheridan BC, Stearns SC, Rossi JS, D’Arcy LP, Federspiel JJ, Carey TS. Three-year outcomes of multivessel revascularization in very
                   elderly acute coronary syndrome patients. Ann Thorac Surg 2010;89:1889-94; discussion 1894-5.
               103. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN,
   114   115   116   117   118   119   120   121   122   123   124